DN
Therapeutic Areas
Genprex Pipeline
| Drug | Indication | Phase |
|---|---|---|
| REQORSA + Tagrisso | EGFRm NSCLC post-TKI | Phase 1/2 |
| REQORSA + Tecentriq | Extensive-Stage SCLC | Phase 1/2 |
| REQORSA | NSCLC | Phase 1/2 |
| GPX-002 | Type 1 & Type 2 Diabetes | Preclinical |
| NPRL2 Gene Therapy | Solid Tumors (e.g., KRAS/STK11 NSCLC) | Preclinical/Research |